15879
Octaethylene glycol
≥95% (oligomer purity)
Synonym(s):
PED-diol (n=8)
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
Assay
≥95% (oligomer purity)
reaction suitability
reagent type: cross-linking reagent
SMILES string
OCCOCCOCCOCCOCCOCCOCCOCCO
InChI
1S/C16H34O9/c17-1-3-19-5-7-21-9-11-23-13-15-25-16-14-24-12-10-22-8-6-20-4-2-18/h17-18H,1-16H2
InChI key
GLZWNFNQMJAZGY-UHFFFAOYSA-N
General description
Octaethylene glycol also known as PED-diol (n=8), is a cross linking reagent commonly used in organic synthesis.
Application
Octaethylene glycol is used as a cross-linking reagent to produce cyclic octaethylene glycol 5-nitroisophthalate. It serves as a starting material for synthesizing heterobifunctionalized clickable oligo(ethylene glycol) linkers and supramolecular polymers.
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Monomers for non-bond crosslinking of vinyl polymers: II. Cyclic octaethylene glycol 5-methacrylamido-isophthalate
European Polymer Journal, 36, 351-357 (2000)
Efficient synthesis of diverse heterobifunctionalized clickable oligo (ethylene glycol) linkers: potential applications in bioconjugation and targeted drug delivery
Organic & Biomolecular Chemistry, 11, 1116-1126 (2013)
An azobenzene-based single-component supramolecular polymer responsive to multiple stimuli in water
Journal of the American Chemical Society, 142, 10069-10078 (2020)
PLoS neglected tropical diseases, 11(11), e0005951-e0005951 (2017-11-28)
The notion that previous infection by Leishmania spp. in endemic areas leads to robust anti-Leishmania immunity, supports vaccination as a potentially effective approach to prevent disease development. Nevertheless, to date there is no vaccine available for human leishmaniasis. We optimized
PloS one, 13(11), e0206324-e0206324 (2018-11-02)
Mucosal vaccine delivery systems have paramount importance for the induction of mucosal antibody responses. Two studies were conducted to evaluate immunogenicity of inactivated AIV antigens encapsulated in poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). In the first study, seven groups of specific pathogen
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service